Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank79
3Y CAGR-31.9%
5Y CAGR+43.4%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-31.9%/yr
Annual compound
5Y CAGR
+43.4%/yr
Recent deceleration
Percentile
P79
Within normal range
vs 5Y Ago
6.1x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.07+586.6%
20240.01-89.9%
20230.10-54.5%
20220.22+137.4%
20210.09+711.0%
20200.01-
20190.00-
20180.00-
20170.00+100.0%
2016-3.47-